193 related articles for article (PubMed ID: 15767450)
1. Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro.
Chen A; Divisconte M; Jiang X; Quink C; Wang F
J Virol; 2005 Apr; 79(7):4506-9. PubMed ID: 15767450
[TBL] [Abstract][Full Text] [Related]
2. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Chen A; Zhao B; Kieff E; Aster JC; Wang F
J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
[TBL] [Abstract][Full Text] [Related]
3. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.
Jiang H; Cho YG; Wang F
J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073
[TBL] [Abstract][Full Text] [Related]
4. EBNA2 and Its Coactivator EBNA-LP.
Kempkes B; Ling PD
Curr Top Microbiol Immunol; 2015; 391():35-59. PubMed ID: 26428371
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
Cohen JI; Wang F; Mannick J; Kieff E
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9558-62. PubMed ID: 2556717
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
7. C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.
Cancian L; Bosshard R; Lucchesi W; Karstegl CE; Farrell PJ
PLoS Pathog; 2011 Jul; 7(7):e1002164. PubMed ID: 21857817
[TBL] [Abstract][Full Text] [Related]
8. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E
Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331
[TBL] [Abstract][Full Text] [Related]
9. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro.
Tomkinson B; Kieff E
J Virol; 1992 May; 66(5):2893-903. PubMed ID: 1313908
[TBL] [Abstract][Full Text] [Related]
10. An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A.
Lee W; Hwang YH; Lee SK; Subramanian C; Robertson ES
J Virol; 2001 Sep; 75(18):8556-68. PubMed ID: 11507201
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells.
Roth G; Curiel T; Lacy J
Blood; 1994 Jul; 84(2):582-7. PubMed ID: 8025284
[TBL] [Abstract][Full Text] [Related]
12. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K
Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
Allday MJ; Crawford DH; Griffin BE
J Gen Virol; 1989 Jul; 70 ( Pt 7)():1755-64. PubMed ID: 2544663
[TBL] [Abstract][Full Text] [Related]
14. Comparative sequence analyses of Epstein-Barr virus nuclear antigen-2 and -3B genes of a fresh Epstein-Barr virus-2 isolate.
Inoue N; Kikuta H; Yanagi K
Intervirology; 1992; 33(4):180-6. PubMed ID: 1339417
[TBL] [Abstract][Full Text] [Related]
15. Immortalizing genes of Epstein-Barr virus.
Middleton T; Gahn TA; Martin JM; Sugden B
Adv Virus Res; 1991; 40():19-55. PubMed ID: 1659776
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
McClain K; Estrov Z; Raju U; Kelley PK; Aggarwal BB
Methods; 1997 Jan; 11(1):83-7. PubMed ID: 8990093
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Epstein-Barr virus regulatory sequences upstream of the EBNA gene promoter Wp1 is unfavorable for B-Cell immortalization.
Yoo LI; Woloszynek J; Templeton S; Speck SH
J Virol; 2002 Nov; 76(22):11763-9. PubMed ID: 12388739
[TBL] [Abstract][Full Text] [Related]
18. [Studies on transforming functions of Epstein-Barr virus-specific proteins].
Kinoshita T
Hokkaido Igaku Zasshi; 1990 Jul; 65(4):362-75. PubMed ID: 2172130
[TBL] [Abstract][Full Text] [Related]
19. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
[TBL] [Abstract][Full Text] [Related]
20. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.
Tomkinson B; Kieff E
J Virol; 1992 Feb; 66(2):780-9. PubMed ID: 1309912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
